… This systematic review aimed to determine the comparative accuracy of risk assessment …
The aim of this systematic review was to identify primary validation studies (as derivation studies …

… The total annual health-care costs associated with venous thromboembolism are
estimated to range between €1·5–3·3 billion in Europe, and US$7–10 billion in the USA. …

… fatal pulmonary embolism. Prospective studies identified during our systematic literature review
… these findings by reporting few fatalities directly attributable to venous thromboembolism. …

… risk of venous thromboembolism events (VTE). This study performed a systematic review
in … screened/assessed for deep vein thrombosis (DVT) and/or for pulmonary embolism (PE). …

… venous thromboembolism. b Low-risk patients: younger than 50 years, no cancer or prior
venous thromboembolism, … embolism: a systematic review and individual-patient data meta-…

… A 2014 systematic review reported annual VTE incidence rates ranging from 0.75 to 2.69
per 1000 individuals in 12 studies from Western Europe, North America, East Asia, and …

… literature review were used to estimate the economic burden of illness, including direct medical
costs … and recurrent venous thromboembolism, all of which carry an additional healthcare …

… (DVT) was considered low compared with pulmonary embolism (PE), which led researchers
… , supporting systematic studies. Thus, we aimed to systematically review the literature and …

… mortality, and high economic costs. The … venous thromboembolic disease was 17.8% (9.9–27.4).
The incidence of superficial vein thrombosis, DIC, ACS/MI, catheter-related thrombosis…

… (PE), is a frequent cause of morbidity and mortality in patients with cancer and is associated
with a high economic burden.[1] [2] The therapeutic management of VTE in cancer patients …